Prevalence and clinical importance of inhibitory antibodies in patients with cystic fibrosis and chronic Pseudomonas aeruginosa pulmonary infections (2020-2022)
Experts
Miss
Emma Louise Ledger
Research Officer
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences